Morris David K 4

What Happened

• Morris David K, Executive Vice President and Chief Financial Officer of Guardian Pharmacy Services, was granted a derivative award on Feb 11, 2026: 50,000 shares reported as a grant/award (transaction code A) at $0.00 per share. The instrument is reported as a derivative (an option-like award) rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-02-11; Form 4 filed: 2026-02-13 (appears timely within the standard two-business-day window).
• Award: 50,000 shares reported as a derivative grant at $0.00 per share.
• Vesting/exercise: Footnote states the option "shall vest and become exercisable in full on February 11, 2029."
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: confirms this is an option-style award with full vesting and exercisability on 2029-02-11.
• No indication of a 10b5-1 plan, tax withholding, or immediate sale in this filing.

Context

• This was a grant of a derivative award (option) rather than an outright purchase or sale; no cash changed hands at grant and the award will not be exercisable until the stated vesting date in 2029. Grants like this are common as long-term incentive compensation and do not by themselves indicate immediate buying or selling activity.